Cargando…

Gender and racialisation of pharmaceutical sector leaders in Canada: a cross-sectional study

OBJECTIVE/DESIGN: Lacking diversity in pharmaceutical leadership positions could contribute to inequities in medicine access. The objective of this cross-sectional study was to determine the gender and racial identities of individuals who hold leadership positions in the Canadian pharmaceutical sect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Satgunanathan, Kasthuri, Workentin, Aine, Woods, Hannah, Sabir, Areesha, Persaud, Nav
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2023
Materias:	Health Policy
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10649613/ https://www.ncbi.nlm.nih.gov/pubmed/37963692 http://dx.doi.org/10.1136/bmjopen-2023-076235

Ejemplares similares

Effect of free medicine distribution on ability to make ends meet: post hoc quantitative subgroup analysis and qualitative thematic analysis
por: Hess, Margaret, et al.
Publicado: (2022)

Recommendations for equitable COVID-19 pandemic recovery in Canada
por: Persaud, Nav, et al.
Publicado: (2021)

National patient groups in Canada and their disclosure of relationships with pharmaceutical companies: a cross-sectional study
por: Lexchin, Joel, et al.
Publicado: (2022)

Comparison of drug coverage in Canada before and after the establishment of the pan-Canadian Pharmaceutical Alliance
por: Milliken, Debbie, et al.
Publicado: (2015)

Recommandations pour une reprise équitable après la pandémie de COVID-19 au Canada
por: Persaud, Nav, et al.
Publicado: (2022)

How Can Journals Respond to Threats of Libel Litigation?
por: Persaud, Nav, et al.
Publicado: (2014)

The Brain Health Diplomat's Toolkit: supporting brain health diplomacy leaders in Latin America and the Caribbean
por: Dawson, Walter D., et al.
Publicado: (2023)

Comparing pharmaceutical company payments in the four UK countries: a cross-sectional and social network analysis
por: Rickard, Emily, et al.
Publicado: (2023)

Disclosure of payments by pharmaceutical companies to healthcare professionals in the UK: analysis of the Association of the British Pharmaceutical Industry’s Disclosure UK database, 2015 and 2016 cohorts
por: Mulinari, Shai, et al.
Publicado: (2018)

Incremental benefits of novel pharmaceuticals in the UK: a cross-sectional analysis of NICE technology appraisals from 2010 to 2020
por: Polak, Tobias B, et al.
Publicado: (2022)

Undisclosed financial ties between guideline writers and pharmaceutical companies: a cross-sectional study across 10 disease categories
por: Moynihan, Ray, et al.
Publicado: (2019)

Public performance reporting and hospital choice: a cross-sectional study of patients undergoing cancer surgery in the Australian private healthcare sector
por: Prang, Khic-Houy, et al.
Publicado: (2018)

Changes in the type and amount of spending disclosed by Australian pharmaceutical companies: an observational study
por: Parker, Lisa, et al.
Publicado: (2019)

Physicians’ attitudes towards disclosure of payments from pharmaceutical companies in a nationwide voluntary transparency database: a cross-sectional survey
por: Stoll, Marlene, et al.
Publicado: (2022)

Primary care performance of alternatively licenced physicians in Ontario, Canada: a cross-sectional study using administrative data
por: Hodwitz, Kathryn, et al.
Publicado: (2019)

Successful childhood obesity management in primary care in Canada: what are the odds?
por: Kuhle, Stefan, et al.
Publicado: (2015)

Policies supporting informal caregivers across Canada: a scoping review protocol
por: Khayatzadeh-Mahani, Akram, et al.
Publicado: (2018)

Time to market for drugs approved in Canada between 2014 and 2018: an observational study
por: Lexchin, Joel
Publicado: (2021)

Factors affecting adherence to non-pharmaceutical interventions for COVID-19 infections in the first year of the pandemic in the UK
por: Ding, Xuejie, et al.
Publicado: (2021)

Canada has an opportunity to address antimicrobial resistance through COVID-19 recovery spending
por: Somanader, Deborah S., et al.
Publicado: (2022)

Quality of advertisements for prescription drugs in family practice medical journals published in Australia, Canada and the USA with different regulatory controls: a cross-sectional study
por: Diep, Dion, et al.
Publicado: (2020)

Under-reported relationship: a comparative study of pharmaceutical industry and patient organisation payment disclosures in the UK (2012–2016)
por: Ozieranski, Piotr, et al.
Publicado: (2020)

Voluntary disclosures of payments from pharmaceutical companies to healthcare professionals in Germany: a descriptive study of disclosures in 2015 and 2016
por: Stoll, Marlene, et al.
Publicado: (2020)

What are determinants of utilisation of pharmaceutical anticancer treatment during the last year of life in Norway? A retrospective registry study
por: Bugge, Christoffer, et al.
Publicado: (2021)

Qualitative protocol for understanding the contribution of Australian policy in the urban planning, justice, energy and environment sectors to promoting health and health equity
por: Baum, Fran, et al.
Publicado: (2018)

Introducing a sector-wide pooled fund in a fragile context: mixed-methods evaluation of the health transition fund in Zimbabwe
por: D’Aquino, Luigi, et al.
Publicado: (2019)

Gender differences on medical students’ attitudes toward patient-centred care: a cross-sectional survey conducted in Heilongjiang, China
por: Liu, Wei, et al.
Publicado: (2019)

COVID-19 incidence and mortality in Nigeria: gender based analysis
por: Olusola-Makinde, Olubukola O., et al.
Publicado: (2021)

Assessing variation among the national essential medicines lists of 21 high-income countries: a cross-sectional study
por: Taglione, Michael Sergio, et al.
Publicado: (2021)

An analysis of redactions in Canada’s Common Drug Review Clinical Review Reports and how they relate to the patients’ voice
por: Soprovich, Allison, et al.
Publicado: (2017)

Piecing together the Inuit food security policy puzzle in Nunatsiavut, Labrador (Canada): protocol for a scoping review
por: Bowers, Renee, et al.
Publicado: (2019)

Interactions between physicians and the pharmaceutical industry generally and sales representatives specifically and their association with physicians’ attitudes and prescribing habits: a systematic review
por: Fickweiler, Freek, et al.
Publicado: (2017)

Postmarket safety in Canada: are significant therapeutic advances and biologics less safe than other drugs? A cohort study
por: Lexchin, Joel
Publicado: (2014)

Integrating Indigenous healing practices within collaborative care models in primary healthcare in Canada: a rapid scoping review
por: Corso, Melissa, et al.
Publicado: (2022)

Emergency contracting and the delivery of elective care services across the English National Health Service and independent sector during COVID-19: a descriptive analysis
por: Friebel, Rocco, et al.
Publicado: (2022)

A systematic analysis of UK cancer research funding by gender of primary investigator
por: Zhou, Charlie D, et al.
Publicado: (2018)

Longitudinal analyses of gender differences in first authorship publications related to COVID-19
por: Lerchenmüller, Carolin, et al.
Publicado: (2021)

Choosing appropriate tools and referral criteria for vision screening of children aged 4–5 years in Canada: a quantitative analysis
por: Nishimura, Mayu, et al.
Publicado: (2019)

The rights and interests of First Nations, Métis, and Inuit in debates over deemed consent legislation for deceased organ donation in Canada: calls to action
por: Tait, Caroline L.
Publicado: (2023)

Gender differences in faculty rank among academic physicians: a systematic review and meta-analysis
por: Li, Ben, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_i5d81n5v5vs3vcjuvko32e0lii